Only pay if approved·Free shipping·Cancel anytime·Provider supervised·HIPAA secure

Provider-prescribed treatments. Subject to medical evaluation. Medications are dispensed by licensed U.S. pharmacies.

Back to Blog
Comparisons
🔗 Linkable Asset 5/8/2026 7 min readBy EdenRx Medical Team

Semaglutide vs Liraglutide: Comparing Two GLP-1 Weight Loss Options

Semaglutide vs Liraglutide: Comparing Two GLP-1 Weight Loss Options

Ready to find out if you may qualify?

No payment required to start · Takes less than 60 seconds · Only pay if approved

Check Your Eligibility Free
No Payment Required Response Within 24h Built from Eden Med Spa

Key Takeaways

  • 1Semaglutide is dosed once weekly while liraglutide requires daily injections — a key convenience difference for many patients.
  • 2Clinical trials suggest semaglutide may produce greater average weight loss (~15%) compared to liraglutide (~5–8%), though individual results vary.
  • 3Both medications share a similar GI side effect profile and require provider review — only a licensed clinician can determine which, if either, is right for you.
  • 4EdenRx offers provider-reviewed GLP-1 programs to eligible patients in Florida and New York, with a free assessment to get started.
  • 5No weight loss outcomes are guaranteed; results vary based on individual health history, adherence, and lifestyle factors.

Both semaglutide and liraglutide belong to the GLP-1 receptor agonist class and may potentially support significant weight loss in eligible patients — but they are not interchangeable. Dosing frequency, clinical outcomes, and side effect profiles differ meaningfully between the two, and only a licensed provider can determine which medication is appropriate for your individual health history.

Ready to find out if you qualify? Start Free Assessment — No payment required.


What Are GLP-1 Receptor Agonists?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a naturally occurring hormone released in the gut after eating. By activating GLP-1 receptors, these drugs may slow gastric emptying, reduce appetite signals in the brain, and help regulate blood sugar — all of which can contribute to reduced caloric intake and, if eligible, meaningful weight loss over time.

Both semaglutide and liraglutide work through this same fundamental mechanism, which is why they are often compared side by side. However, their molecular structures, half-lives, and approved dosing schedules differ — and those differences can matter significantly when a provider is selecting the right treatment plan for a specific patient. To learn more about how this class works at the cellular level, visit our guide on how semaglutide works.


Semaglutide vs Liraglutide: A Side-by-Side Comparison

The table below summarizes the key differences between semaglutide and liraglutide based on available clinical data and prescribing information. This is intended for informational purposes only — results vary, and your provider will determine what is appropriate for you.

| Feature | Semaglutide | Liraglutide | |---|---|---| | Brand Names | Ozempic®, Wegovy® | Victoza®, Saxenda® | | Dosing Frequency | Once weekly (injection) | Once daily (injection) | | FDA-Approved for Weight Loss | Yes (Wegovy®) | Yes (Saxenda®) | | Average Weight Loss (Clinical Trials) | Up to ~15% body weight (STEP trials) | Up to ~5–8% body weight (SCALE trials) | | Half-Life | ~1 week | ~13 hours | | Common Side Effects | Nausea, vomiting, diarrhea, constipation | Nausea, vomiting, diarrhea, constipation | | Route of Administration | Subcutaneous injection | Subcutaneous injection | | Compounded Version Available | Potentially, if eligible | Less commonly compounded |

Semaglutide's longer half-life allows it to remain active in the body for approximately seven days, which is why it is dosed once weekly. Liraglutide must be administered daily to maintain therapeutic levels. For many patients, the convenience of a once-weekly injection can improve medication adherence, which is a clinically important factor in long-term weight management outcomes.


Efficacy: What the Clinical Data Suggests

The clinical evidence base for semaglutide is notably robust. In the STEP 1 trial, participants using semaglutide 2.4 mg weekly experienced an average body weight reduction of approximately 14.9% over 68 weeks. These results represented a significant advancement over earlier GLP-1 therapies. It is important to note, however, that individual results vary and that these outcomes were achieved in conjunction with lifestyle interventions.

Liraglutide's pivotal SCALE Obesity and Prediabetes trial demonstrated average weight loss of approximately 8% over 56 weeks — a clinically meaningful result, though generally lower than what semaglutide trials have shown. Liraglutide was approved by the FDA for chronic weight management earlier than semaglutide and therefore has a longer real-world track record. For patients who may not tolerate semaglutide or who have specific clinical considerations, liraglutide may potentially remain a viable option as determined by a licensed provider.


Side Effects and Tolerability

Both medications share a similar gastrointestinal side effect profile because they act on the same receptor class. The most commonly reported side effects include nausea, vomiting, diarrhea, and constipation, particularly during the dose escalation phase. These effects are typically transient and may diminish as the body adjusts to the medication over the first several weeks of treatment.

Some patients find that the once-daily dosing of liraglutide causes more noticeable day-to-day nausea, while others prefer having more daily control over timing. With semaglutide, side effects may cluster in the day or two following the weekly injection before subsiding. Neither medication is appropriate for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and a thorough provider evaluation is essential before starting either treatment. If you are curious about how semaglutide compares to a newer option in the same drug class, our semaglutide vs tirzepatide breakdown covers those differences in detail.


Why Provider Review Matters

Choosing between semaglutide and liraglutide is not a decision that should be made based on a comparison article alone — and EdenRx is built around that principle. Every patient who starts a program through our platform undergoes a structured assessment reviewed by a licensed provider. That review takes into account your medical history, current medications, metabolic labs, and personal goals before any prescription is issued or recommended.

This provider-first model is not just a regulatory requirement — it is the standard of care. GLP-1 medications carry contraindications, potential drug interactions, and dosing considerations that require clinical judgment. Our providers serving patients in Florida and New York are equipped to evaluate which medication, if any, may be appropriate for your situation. Explore semaglutide availability in Florida or review our program options to understand what a supervised weight loss plan through EdenRx may look like for eligible patients.

Thinking about getting started? View Pricing or Start Your Free Assessment today — no payment required to find out if you qualify.


Built from Eden Med Spa — Real Patients, Real Treatments.

EdenRx grew out of Eden Med Spa, a trusted Florida-based practice with a track record of delivering real treatments to real patients under real clinical supervision. That foundation means our telehealth platform carries the same commitment to safety, compliance, and personalized care that in-person patients have come to expect. We are not a pill mill or a subscription box — we are a provider-reviewed, medically supervised weight loss program available to eligible patients in Florida and New York. Results vary, and no outcomes are guaranteed, but every recommendation we make is grounded in clinical evidence and individual patient evaluation.


Frequently Asked Questions

Is semaglutide stronger than liraglutide?

Clinical trial data suggests that semaglutide may produce greater average weight loss than liraglutide at approved doses — approximately 15% vs. 5–8% of body weight in respective pivotal trials. However, "stronger" does not always mean "better for you." Individual tolerability, medical history, and clinical goals all influence which medication a provider may recommend.

Can I switch from liraglutide to semaglutide?

A transition between GLP-1 medications is possible for some patients, but it must be managed by a licensed provider. Dosing adjustments, washout periods, and monitoring requirements apply. Do not switch medications without guidance from a qualified healthcare professional.

How often do I inject each medication?

Semaglutide is typically administered once weekly via subcutaneous injection. Liraglutide requires a once-daily injection. For patients who prefer less frequent dosing, semaglutide's weekly schedule may be more convenient, though adherence factors vary by individual.

Are these medications available through EdenRx?

EdenRx offers provider-reviewed access to GLP-1 weight loss medications, including compounded semaglutide, to eligible patients in Florida and New York. Availability is subject to provider assessment and applicable regulations. Start your free assessment to find out what options may be available to you.

What side effects should I watch for?

The most common side effects of both semaglutide and liraglutide include nausea, vomiting, diarrhea, and constipation — especially during the dose escalation phase. Serious but rare side effects include pancreatitis and gallbladder disease. Always report new or worsening symptoms to your provider promptly.

Does insurance cover semaglutide or liraglutide for weight loss?

Insurance coverage varies widely depending on your plan, diagnosis, and the specific brand prescribed. Some plans cover Wegovy® or Saxenda® for obesity with prior authorization, while others do not. EdenRx offers transparent pricing for patients pursuing self-pay options, and our team can help clarify what to expect.


Conclusion: The Right GLP-1 Is the One Your Provider Recommends

When comparing semaglutide vs liraglutide, the data generally favors semaglutide for magnitude of weight loss and dosing convenience — but clinical decisions are never made by data tables alone. Your provider will weigh your complete health picture to determine whether either medication is appropriate, and if so, which one aligns best with your needs and goals. Both medications may potentially support meaningful weight loss in the right candidates, and both require medical supervision to use safely.

If you are ready to explore your options with a licensed provider, EdenRx makes it simple. Our free assessment takes just minutes, requires no payment to start, and connects you with a provider-reviewed program designed for eligible patients in Florida and New York.

Take the first step. Start Your Free Assessment — No payment required. Results vary. Available to eligible patients in FL and NY only.

See if you qualify in 60 seconds

Provider-reviewed · Only pay if approved · Cancel anytime

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
semaglutide liraglutide GLP-1 weight loss telehealth comparisons Florida New York EdenRx obesity treatment

Share This Article

Share Text

Semaglutide vs liraglutide — which GLP-1 is right for you? Weekly vs daily dosing, efficacy data, and side effects compared. Only a provider can decide, but here's what to know first. 👉 tryedenrx.org #WeightLoss #GLP1 #Semaglutide

No payment required to start — get up to $50 off your first month.

A licensed provider reviews every case. Only pay if approved. Cancel anytime.

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
Live Activity
127 people online now
1,076 visits today
10 orders shipped today
HIPAA Secure